Myasthenia gravis and hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 3, Issue 6, 1996, Pages 329-332

  Halfon, P ^a,b,e   Levy, M ^a   San Marco, M ^c   Gerolami, V ^a   Khiri, H ^b   Bourliere, M ^d   Feryn, J M ^b   Gastaut, J L ^c   Pouget, J ^c   Cartouzou, G ^a  

^a La Conception University Hospital   (France)

^b Laboratoire Alphabio   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d HÔPITAL SAINT JOSEPH   (France)

^e Hospital Ambroise Pare   (France)

Author keywords

HCV RNA; HCVAb; Hepatitis; Hepatitis C virus; Myasthenia gravis; Polymerase chain reaction

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CLASSIFICATION; CONGENITAL MALFORMATION; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RETROSPECTIVE STUDY; THYMUS; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RETROSPECTIVE STUDIES; RNA, VIRAL; THYMUS GLAND;

EID: 0030279946     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.1996.tb00106.x     Document Type: Article

References (23)

1. Goulon M, Gajdos P, Goulon-Goeau P. La myasthénie, modèle de maladie par auto-anticorps. Progrès récents en immunopathologie. 45ème congrès français de médecine, Paris 1985.
2. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to Ach-R in myasthenia gravis. Neurology 1976; 26: 1054-1059.
3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.
4. Mishiro S, Hoshi Y, Yoshikawa A et al. An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen. Autiommunity 1991; 19: 269-273.
5. Lenzi M, Ballardini G, Fusconi M et al. Type II autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 258-259.
6. Tran A, Quaranta JF, Benzaken S et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993; 18: 253-257.
7. Cacoub P, Lunel-Fabiani F, Musset L et al. Hepatitis C virus and essential mixed cryoglobulinemia. Am J Med 1994; 96: 124-131.
8. Haddad J, Deny P, Munz-Gotheil C et al. Lymphocytic sialadenitis of Sjögren syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-323.
9. Divano MC, Parodi A, Rebora A. Lichen planus, liver kidney microsomal (LKM1) antibodies and hepatitis C virus antibodies. Dermatology 1992; 185: 132-133.
10. Pawlotsky JM, Bouvier M, Fromont P et al. Hepatitis C virus infection and autoimmune thrombocytopenic purpura. 1995; 23: 635-639.
11. Zuffi M, Antozzi C, Confalonieri P et al. Prevalence and genotypes for hepatitis C virus in an Italian myasthenia gravis population. Fourth European Conference on Myasthenia Gravis. Versailles, April 1994.
12. Vernet-der Garabedian B, Pawlotsky JM, Authier FJ et al. Myasthenia gravis and hepatitis C virus infection. Fourth European Conference on Myasthenia Gravis. Versailles, April 1994.
13. Young KK, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993; 31: 882-886.
14. Stuyver L, Rossau R, Wyseur A et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1092-1102.
15. Simmonds P, Holmes EC, Cha TA et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetics analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-2399.
16. Chan TM, Lok ASF, Cheng IKP, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients. A longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993; 17: 5-8.
17. Roudot-Thoraval F, Pawlotsky JM, Deforges L, Girollet PP, Dhumeaux D. Anti-HCV seroprevalence in pregnant women in France. Gut 1993; 34: S55-56.
18. Fukui T, Sugita K, Ichikawa H, Negishi A, Kasai H, Tsukagoshi H. Human T lymphotropic virus type 1 associated myelopathy and myasthenia gravis: a possible association? Eur Neurol 1994; 34: 158-161.
19. Schwimmbeck PL, Dryberg T, Drachmann DB, Oldstone MBA. Molecular mimicry, and myasthenia gravis: an autoantigenic site of the acetylcholine receptor alpha subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest 1989; 84: 1174-1180.
20. Thornton CA, Griggs RC. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neurol 1994; 35: 260-268.
21. Zhang WH, Liu CB, De Sun Y et al. Hepatitis C virus causing non A, non B hepatitis in plasmapheresis centre. Lancet 1990; 335: 353.
22. PawlotskyJM, Bouvier M, Deforges L, Duval J, Bierling P, Dhumeaux D. Chronic hepatitis C after high dose intravenous immunoglobulin. Transfusion 1994; 34: 86-87.
23. Allander T, Gruber A, Naghavi M et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345: 603-606.